Results
53
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
53 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MNTC New | SEK 25.20 | 1.6% | -47.9% | SEK 644.3m | SEK 42.67 | PS2.3x | E116.7% | 0% | Healthcare | ||
DYVOX New | SEK 68.80 | 14.3% | 63.8% | SEK 7.3b | SEK 71.00 | PE52.6x | E34.9% | n/a | Tech | ||
NWG | SEK 175.20 | 0.5% | 5.2% | SEK 4.2b | SEK 168.25 | PE20.9x | E23.6% | 2.9% | Capital Goods | ||
MERIS New | SEK 0.51 | 3.1% | -8.5% | SEK 437.7m | SEK 0.47 | PS0.5x | E82.8% | n/a | Capital Goods | ||
EKTA B New | SEK 63.50 | 3.9% | -15.6% | SEK 24.3b | SEK 72.54 | PE24.2x | E21.1% | 1.9% | Healthcare | ||
EWRK | SEK 149.80 | -1.8% | 6.4% | SEK 2.6b | n/a | PE19.7x | E20.7% | 4.7% | Commercial Services | ||
PIERCE | SEK 7.54 | 1.6% | 16.0% | SEK 598.5m | SEK 12.40 | PS0.4x | E71.6% | n/a | Retail | ||
LIAB | SEK 191.00 | -5.0% | 2.0% | SEK 14.7b | SEK 258.67 | PE21.7x | E27.0% | 2.8% | Capital Goods | ||
SUS New | SEK 175.00 | 15.7% | 0.9% | SEK 8.9b | SEK 192.17 | PE46.2x | E36.1% | n/a | Healthcare | ||
VERT B | SEK 51.40 | -1.5% | 96.2% | SEK 1.4b | SEK 61.00 | PE38.6x | E44.4% | 0% | Software | ||
BMAX | SEK 46.54 | 5.2% | 28.6% | SEK 2.7b | SEK 48.00 | PE82.7x | E80.5% | 1.1% | Retail | ||
ENEA | SEK 102.00 | 2.1% | 95.4% | SEK 2.0b | SEK 127.50 | PE33.4x | E32.8% | 0% | Software | ||
STIL New | SEK 245.00 | 18.4% | 62.8% | SEK 2.2b | SEK 269.50 | PE43.3x | E36.8% | 0% | Healthcare | ||
NREST | SEK 113.00 | 1.1% | n/a | SEK 1.4b | SEK 155.00 | PE12.6x | E20.2% | n/a | Consumer Services | ||
ABSO | SEK 277.00 | 3.4% | -30.6% | SEK 3.1b | SEK 402.00 | PE24.9x | E24.8% | 1.1% | Capital Goods | ||
BHG | SEK 19.80 | 13.2% | 56.5% | SEK 3.5b | SEK 21.00 | PS0.4x | E107.7% | n/a | Retail | ||
TFBANK | SEK 406.00 | 6.3% | 148.5% | SEK 8.7b | SEK 456.67 | PB3.5x | E22.3% | n/a | Banks | ||
BIOA B | SEK 195.60 | -0.2% | -16.7% | SEK 17.3b | SEK 322.00 | PS103.4x | E51.3% | 0% | Pharmaceuticals & Biotech | ||
NORVA | SEK 25.10 | -1.0% | -12.2% | SEK 4.6b | SEK 35.20 | PE24.1x | E20.0% | n/a | Commercial Services | ||
W5 | SEK 53.50 | 13.3% | -39.2% | SEK 810.3m | SEK 57.83 | PS2x | E112.8% | n/a | Capital Goods | ||
EPRO B | SEK 71.50 | 9.0% | 33.0% | SEK 20.5b | SEK 77.00 | PE27.1x | E20.4% | 1.1% | Capital Goods | ||
FAG | SEK 56.10 | 2.0% | -11.2% | SEK 9.9b | SEK 72.00 | PE24.2x | E24.4% | 3.2% | Capital Goods | ||
ERIC B | SEK 95.08 | 6.0% | 55.2% | SEK 316.9b | SEK 84.58 | PS1.3x | E73.1% | 2.8% | Tech | ||
NETI B | SEK 6.94 | -0.4% | 27.7% | SEK 2.4b | SEK 8.25 | PE28.3x | E22.5% | n/a | Tech |